LITS

Insider Trades

Name	Value	Action	Price	Current Price
Flynn James PDirector $98k70k shares BuyDec 19, 2025 $1.40 --
Schornstein Alexander10 Percent Owner $946k690.6k shares SellDec 18, 2025 $1.37 --
Flynn James PDirector $23k12.1k shares BuyNov 19, 2025 $1.88 --

News

globenewswire.comLite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdamglobenewswire.comJun 19

globenewswire.comLite Strategy Leads Strategic Investment in LitVMglobenewswire.comJun 18

globenewswire.comLite Strategy Reports Fiscal 2026 Third Quarter Resultsglobenewswire.comMay 13

Trade LITS

About Lite Strategy, Inc.

Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.

CEO: Justin J. File
IPO Date: Dec 18, 2003

Market Data

Open: $0.9019
High: $0.9194
Low: $0.803
Volume: 584.3K
Avg Volume: 392.2K
52W High: $9.00
52W Low: $0.69

Valuation

Market Cap: $28M
Enterprise Value: $21M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-21M
Revenue: $0
Net Income: $-16M
Cash: $18M
Debt: $0

Events

EarningsSep 18

EPS est. -3.116